Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Geraint Rogers, Mary Carroll, Kenneth Bruce

    Research output: Contribution to journalReview articlepeer-review

    22 Citations (Scopus)


    The discovery of novel classes of antibiotics has slowed dramatically. This has occurred during a time when the appearance of resistant strains of bacteria has shown a substantial increase. Concern is therefore mounting over our ability to continue to treat infections in an effective manner using the antibiotics that are currently available. While ongoing efforts to discover new antibiotics are important, these must be coupled with strategies that aim to maintain as far as possible the spectrum of activity of existing antibiotics. In many instances, the resistance to antibiotics exhibited by bacteria in chronic infections is mediated not by direct resistance mechanisms, but by the adoption of modes of growth that confer reduced susceptibility. These include the formation of biofilms and the occurrence of subpopulations of 'persister' cells. As our understanding of these processes has increased, a number of new potential drug targets have been revealed. Here, advances in our ability to disrupt these systems that confer reduced susceptibility, and in turn increase the efficacy of antibiotic therapy, are discussed.

    Original languageEnglish
    Pages (from-to)845-857
    Number of pages13
    JournalBritish Journal of Pharmacology
    Issue number4
    Publication statusPublished - Feb 2012


    • antibiotic resistance
    • bacteriophage therapy
    • biofilm
    • macrolide antibiotics
    • persister
    • quorum sensing
    • viable non-culturable


    Dive into the research topics of 'Enhancing the utility of existing antibiotics by targeting bacterial behaviour?'. Together they form a unique fingerprint.

    Cite this